By Bertram K. Two days after his death in May, Zach Sobiech’s song “Clouds” became the number one download on iTunes and now has surpassed seven million views on YouTube....

A study published recently in Science by Susanne Horn and colleagues is a noteworthy example of hypothesis-driven science done right. It exemplifies how seemingly obscure findings can lead to new...

Dave Hinds is a Principal Scientist in Statistical Genetics.   Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. 23andMe is passionate about...

Understanding the molecular profile of a cancer cell can help physicians understand which drugs will be effective in treating the cancer.

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have – to find the causes...

By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I...

23andMe is passionate about fighting cancer. We recently launched a Cancer Family History survey and within two months more than 20,000 customers have answered! We're already learning some very interesting things -- read on.

Sarcoma is a rare form of cancer that is often caused by two genes fusing together but which two genes are involved can be different between different types of sarcoma. A group of French researchers recently discovered a new gene fusion characterizing a type of "Ewing-like" sarcomas.

On a recent visit to 23andMe George Demetri –a physician and scientist who is an unpaid advisor to our Sarcoma research initiative – sat down for a short interview after...

It’s hard to picture a more “personalized” approach to medicine than Dr. Ronald Levy’s. Levy, chief of the oncology division at Stanford University’s School of Medicine, has spent his career...